From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...

The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the third quarter of 2025 of $0.22 per Class A ordinary share. The dividend will be paid on ...

DelveInsight's Type 1 Diabetes pipeline report depicts a robust space with 85+ active players working to develop 100+ ...

Vertex Pharmaceuticals Inc. closed 10.89% short of its 52-week high of $519.88, which the company achieved on November 8th.